FDA Clearance Tracker · P220015
DilightTM (roflufocon E) Overnight Orthokeratology Contact Lens
Last checked: Nov 19, 2026Latest source record: Aug 5, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 5, 2026
Approved
Time to decision
1,422 days
Received Sep 13, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P220015
- Device name
- DilightTM (roflufocon E) Overnight Orthokeratology Contact Lens
- Applicant location
- Tianjin
- Received
- Sep 13, 2022
- Decided
- Aug 5, 2026
- Decision
- Approved
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.5916
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for DilightTM (roflufocon E) Overnight Orthokeratology Contact Lens. The lenses are indicated for use in the reduction of myopic refractive error in non-diseased eyes. The lens is indicated for overnight wear for the temporary reduction of myopia up to 4.00 diopters (manifest spherical equivalent) in eyes with astigmatism up to 1.50 diopters. The lenses may only be disinfected using a chemical disinfection system. Note: To maintain the Orthokeratology effect overnight lens wear must be continued on a prescribed schedule. Failure to do so can affect daily activities (e.g., night driving), cause visual fluctuations, and changes in intended correction.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NUU. The earliest in FDA's data is P870024-S043, decided Jun 13, 2002.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Tianjin MasterVision Technology Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241398 · Decided Oct 22, 2024 · 159 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.